Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Expert Ratings for Personalis

Personalis (NASDAQ:PSNL) has observed the following analyst ratings within the last quarter:

Benzinga

Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action

Clover Biopharmaceuticals Ltd announced new promising data from a preclinical study on its bivalent vaccine candidate, which combines the trimeric spike antigens from the original SARS-CoV-2 strain and the omicron variant. Clover developed the SCB-2019 antigen, a stabilized trimeric form of the S-protein based on the original strain of the SARS-CoV-2 virus. It…

Benzinga

Mid-Day Market Update: U.S. Stocks Extend Losses; Dow Dips Over 1,100 Points

U.S. stocks extended losses midway through trading, with the Dow Jones dipping more than 1,100 points on Thursday.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Preview: Liberty Formula One Group's Earnings

Liberty Formula One Group (NASDAQ:FWONK) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Liberty Formula One Group will report an earnings per share (EPS) of $-0.21.

Benzinga

A Preview Of Calumet Specialty's Earnings

Calumet Specialty (NASDAQ:CLMT) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Calumet Specialty will report an earnings per share (EPS) of $-0.52.

Benzinga

Novavax Seeks Approval For COVID-19 Shot Among Adolescents In Britain

Novavax Inc (NASDAQ:NVAX) filed an application with Britain's drugs regulator for the authorization of its COVID-19 vaccine among adolescents aged 12 and older. Britain had in February cleared the two-dose vaccine, Nuvaxovid, for use in adults. Novavax's submission includes data from a late-stage trial in the U.S., where the vaccine showed 80% efficacy among…

Benzinga

What 4 Analyst Ratings Have To Say About Morphic Holding

Over the past 3 months, 4 analysts have published their opinion on Morphic Holding (NASDAQ:MORF) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

57 Stocks Moving In Thursday's Mid-Day Session

Gainers

Benzinga

Jazz Pharma, Sumitomo Pharma Ink Licensing Pact For Sleeping Disorder Candidate

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has acquired development and commercialization rights in the U.S., Europe, and other territories for Sumitomo Pharma's investigational DSP-0187. DSP-0187 is a potent, highly selective oral orexin-2 receptor agonist with potential application for treating narcolepsy, idiopathic hypersomnia, and other sleep disorders. Jazz has designated this molecule JZP441. Sumitomo Pharma initiated a Phase…

Benzinga

Earnings Outlook For Athersys

Athersys (NASDAQ:ATHX) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Athersys will report an earnings per share (EPS) of $-0.10.

Benzinga

Capital Product Partners Earnings Preview

Capital Product Partners (NASDAQ:CPLP) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Capital Product Partners will report an earnings per share (EPS) of $0.95.

Benzinga

Wells Fargo Maintains Overweight Rating for Morphic Holding: Here's What You Need To Know

Wells Fargo has decided to maintain its Overweight rating of Morphic Holding (NASDAQ:MORF) and lower its price target from $81.00 to $79.00. Shares of Morphic Holding are trading down 3.76% over the last 24 hours, at $33.25 per share.

Benzinga

Preview: Ruth's Hospitality Group's Earnings

Ruth's Hospitality Group (NASDAQ:RUTH) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Ruth's Hospitality Group will report an earnings per share (EPS) of $0.30.

Benzinga

What 6 Analyst Ratings Have To Say About Hostess Brands

Hostess Brands (NASDAQ:TWNK) has observed the following analyst ratings within the last quarter:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Raymond James Maintains Outperform Rating for Upland Software: Here's What You Need To Know

Raymond James has decided to maintain its Outperform rating of Upland Software (NASDAQ:UPLD) and lower its price target from $30.00 to $24.00. Shares of Upland Software are trading down 10.11% over the last 24 hours, at $13.91 per share.

Benzinga

What To Know About B of A Securities's Downgrade of Sprouts Farmers Market

B of A Securities downgraded its rating of Sprouts Farmers Market (NASDAQ:SFM) to Underperform with a price target of $25.00, changing its price target from $40.00 to $25.00. Shares of Sprouts Farmers Market are trading down 23.11% over the last 24 hours, at $24.11 per share.

Benzinga

Piper Sandler Maintains Overweight Rating for eBay: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of eBay (NASDAQ:EBAY) and lower its price target from $68.00 to $63.00. Shares of eBay are trading down 9.28% over the last 24 hours, at $49.37 per share. A move to $63.00 would account for a 27.61% increase from the current…

Benzinga

If You Invested $1000 In Match Group 5 Years Ago, Here's How Much You Would Have Today

Match Group (NASDAQ:MTCH) has outperformed the market over the past 5 years by 20.1% on an annualized basis producing an average annual return of 31.7%. Currently, Match Group has a market capitalization of $21.62 billion.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why AMD Shares Are Falling

Shares of several companies in the broader tech sector, including Advanced Micro Devices, Inc. (NASDAQ: AMD), are trading lower amid overall weakness as traders continue to digest Wednesday's Fed rate hike announcement. An increase in yields has pressured tech and growth stocks.

Benzinga

Why Nvidia Shares Are Diving

Shares of several companies in the broader tech sector, including NVIDIA Corporation (NASDAQ: NVDA), are trading lower amid overall weakness as traders continue to digest Wednesday's Fed rate hike announcement. An increase in yields has pressured tech and growth stocks.

Benzinga

Why Apple Shares Are Falling

Shares of several companies in the broader tech sector, including Apple Inc (NASDAQ: AAPL), are trading lower amid overall weakness as traders continue to digest Wednesday's Fed rate hike announcement. An increase in yields has pressured tech and growth stocks.

Benzinga

Housing Beat: 30-Year Mortgage At 13-Year High; Major Lenders In LinkedIn Spat

The housing and mortgage world witnessed rising rates, an upswing in application levels, and public feud between two major lenders.

Benzinga

Why Tesla Shares Are Diving

Shares of several companies in the broader tech sector, including Tesla Inc (NASDAQ: TSLA), are trading lower amid overall weakness as traders continue to digest Wednesday's Fed rate hike announcement. An increase in yields has pressured tech and growth stocks.

Benzinga

Trading FuelCell Stock? Here's Why A Pull Back May Be Healthy

FuelCell Energy, Inc (NASDAQ: FCEL) was trading more than 9% lower on Thursday, despite printing a bullish Marubozu candlestick on Wednesday, which suggested the stock should trade higher.

Benzinga

Why Microsoft Shares Are Diving

Shares of several companies in the broader tech sector, including Microsoft Corporation (NASDAQ: MSFT), are trading lower amid overall weakness as traders continue to digest Wednesday's Fed rate hike announcement. An increase in yields has pressured tech and growth stocks.

1 … 619 620 621 622

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.